Our study further showed that TNF-α neutralizing antibody combined with a TLR4 inhibitor inhibits the synergistic stimulation of IL-2 and spike protein in monocytes releasing CRS-related inflammatory factors such as IL-1β, IL-6, and IL-8. The gene discussed is IL6; the disease is congenital rubella syndrome.